Foster & Motley Inc Gilead Sciences, Inc. Transaction History

Foster & Motley Inc

$1.46 Billion
Q2 2024

A detailed history of Foster & Motley Inc transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Foster & Motley Inc holds 6,007 shares of GILD stock, worth $529,096. This represents 0.03% of its overall portfolio holdings.

Number of Shares

6,007

Previous 5,954 0.89%

Holding current value

$529,096

Previous $436,000 5.5%

% of portfolio

0.03%

Previous 0.03%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 02, 2024	BUY	$63.15 - $72.88 $3,346 - $3,862	53 Added 0.89%	6,007 $412,000
Q1 2024 Apr 18, 2024	BUY	$71.58 - $87.29 $9,806 - $11,958	137 Added 2.36%	5,954 $436,000
Q4 2023 Feb 01, 2024	BUY	$73.27 - $83.09 $952 - $1,080	13 Added 0.22%	5,817 $471,000
Q3 2023 Oct 24, 2023	BUY	$73.94 - $80.67 $4,658 - $5,082	63 Added 1.1%	5,804 $435,000
Q2 2023 Aug 08, 2023	SELL	$76.01 - $86.7 $8,133 - $9,276	-107 Reduced 1.83%	5,741 $442,000
Q1 2023 May 09, 2023	BUY	$77.31 - $88.08 $11,828 - $13,476	153 Added 2.69%	5,848 $485,000
Q4 2022 Feb 09, 2023	SELL	$62.32 - $89.47 $23,494 - $33,730	-377 Reduced 6.21%	5,695 $489,000
Q3 2022 Nov 04, 2022	BUY	$59.54 - $68.01 $4,167 - $4,760	70 Added 1.17%	6,072 $375,000
Q2 2022 Aug 09, 2022	SELL	$57.72 - $65.01 $17,258 - $19,437	-299 Reduced 4.75%	6,002 $371,000
Q1 2022 Apr 28, 2022	SELL	$57.92 - $72.58 $14,769 - $18,507	-255 Reduced 3.89%	6,301 $375,000
Q4 2021 Jan 25, 2022	SELL	$64.88 - $73.64 $6,942 - $7,879	-107 Reduced 1.61%	6,556 $476,000
Q3 2021 Oct 29, 2021	SELL	$67.69 - $73.03 $96,052 - $103,629	-1,419 Reduced 17.56%	6,663 $465,000
Q2 2021 Jul 20, 2021	BUY	$63.47 - $69.35 $106,312 - $116,161	1,675 Added 26.14%	8,082 $557,000
Q4 2020 Feb 01, 2021	BUY	$56.65 - $64.55 $36,992 - $42,151	653 Added 11.35%	6,407 $373,000
Q3 2020 Oct 19, 2020	BUY	$62.1 - $78.08 $186 - $234	3 Added 0.05%	5,754 $364,000
Q2 2020 Jul 20, 2020	BUY	$72.34 - $84.0 $144 - $168	2 Added 0.03%	5,751 $442,000
Q1 2020 Apr 21, 2020	SELL	$62.63 - $80.22 $18,475 - $23,664	-295 Reduced 4.88%	5,749 $430,000
Q4 2019 Feb 05, 2020	SELL	$61.62 - $67.78 $9,982 - $10,980	-162 Reduced 2.61%	6,044 $393,000
Q3 2019 Oct 24, 2019	BUY	$62.51 - $69.0 $125 - $138	2 Added 0.03%	6,206 $393,000
Q2 2019 Jul 17, 2019	SELL	$61.87 - $69.38 $30,873 - $34,620	-499 Reduced 7.44%	6,204 $419,000
Q1 2019 May 08, 2019	BUY	$62.53 - $70.05 $125 - $140	2 Added 0.03%	6,703 $436,000
Q4 2018 Jan 30, 2019	SELL	$60.54 - $79.0 $6,235 - $8,137	-103 Reduced 1.51%	6,701 $419,000
Q3 2018 Oct 31, 2018	SELL	$71.28 - $78.92 $34,642 - $38,355	-486 Reduced 6.67%	6,804 $525,000
Q2 2018 Jul 24, 2018	SELL	$64.88 - $75.68 $7,331 - $8,551	-113 Reduced 1.53%	7,290 $516,000
Q1 2018 May 14, 2018	SELL	$72.84 - $88.8 $77,793 - $94,838	-1,068 Reduced 12.61%	7,403 $558,000
Q4 2017 Jan 22, 2018	SELL	$71.15 - $83.52 $7,684 - $9,020	-108 Reduced 1.26%	8,471 $607,000
Q3 2017 Oct 19, 2017	BUY	$72.11 - $85.47 $618,631 - $733,247	8,579	8,579 $695,000

Others Institutions Holding GILD

# of Institutions

1,893

Shares Held

1.02B

Call Options Held

12M

Put Options Held

9.04M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Foster & Motley Inc, based on Form 13F filings with the SEC.

News

Stay updated on Foster & Motley Inc with notifications on news.

Account

Foster & Motley Inc Gilead Sciences, Inc. Transaction History